These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11269891)

  • 1. A comparison of insulin suppression tests performed with somatostatin and octreotide with particular reference to tolerability.
    Hwu CM; Kwok CF; Chiang SC; Wang PY; Hsiao LC; Lee SH; Lin SH; Ho LT
    Diabetes Res Clin Pract; 2001 Mar; 51(3):187-93. PubMed ID: 11269891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified method using a somatostatin analogue, octreotide acetate (Sandostatin) to assess in vivo insulin sensitivity.
    Ikebuchi M; Suzuki M; Kageyama A; Hirose J; Yokota C; Ikeda K; Shinozaki K; Todo R; Harano Y
    Endocr J; 1996 Feb; 43(1):125-30. PubMed ID: 8732463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin sensitivity test using a somatostatin analogue, octreotide (Sandostatin).
    Mimura A; Kageyama S; Maruyama M; Ikeda Y; Isogai Y
    Horm Metab Res; 1994 Apr; 26(4):184-7. PubMed ID: 8082872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glipizide treatment on response to an infused glucose load in patients with NIDDM.
    Sheu WH; Jeng CY; Fuh MM; Chen YD; Reaven GM
    Diabetes Care; 1995 Dec; 18(12):1582-7. PubMed ID: 8722055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma leptin concentrations do not appear to decrease insulin-mediated glucose disposal or glucose-stimulated insulin secretion in women with normal glucose tolerance.
    Carantoni M; Abbasi F; Azhar S; Chen YD; Klebanov M; Wang PW; Warmerdam F; Reaven GM
    Diabetes; 1998 Feb; 47(2):244-7. PubMed ID: 9519720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers.
    Yeni-Komshian H; Carantoni M; Abbasi F; Reaven GM
    Diabetes Care; 2000 Feb; 23(2):171-5. PubMed ID: 10868826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified method using somatostatin to assess in vivo insulin resistance over a range of obesity.
    Nagulesparan M; Savage PJ; Unger RH; Bennett PH
    Diabetes; 1979 Nov; 28(11):980-3. PubMed ID: 488547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp.
    Knowles JW; Assimes TL; Tsao PS; Natali A; Mari A; Quertermous T; Reaven GM; Abbasi F
    Metabolism; 2013 Apr; 62(4):548-53. PubMed ID: 23151437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations.
    Krentz AJ; Boyle PJ; Macdonald LM; Schade DS
    Metabolism; 1994 Jan; 43(1):24-31. PubMed ID: 8289671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance.
    Ratzmann KP; Besch W; Witt S; Schulz B
    Diabetologia; 1981 Sep; 21(3):192-7. PubMed ID: 6117492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapting to insulin resistance in obesity: role of insulin secretion and clearance.
    Jung SH; Jung CH; Reaven GM; Kim SH
    Diabetologia; 2018 Mar; 61(3):681-687. PubMed ID: 29196782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test.
    Pei D; Jones CN; Bhargava R; Chen YD; Reaven GM
    Diabetologia; 1994 Aug; 37(8):843-5. PubMed ID: 7988789
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurements of insulin-mediated glucose disposal are stable over time.
    Facchini F; Humphreys MH; Jeppesen J; Reaven GM
    J Clin Endocrinol Metab; 1999 May; 84(5):1567-9. PubMed ID: 10323381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations.
    Rosolová H; Mayer O; Reaven GM
    Metabolism; 2000 Mar; 49(3):418-20. PubMed ID: 10726923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLP-1 does not not acutely affect insulin sensitivity in healthy man.
    Orskov L; Holst JJ; Møller J; Orskov C; Møller N; Alberti KG; Schmitz O
    Diabetologia; 1996 Oct; 39(10):1227-32. PubMed ID: 8897012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome.
    Vigil P; Contreras P; Alvarado JL; Godoy A; Salgado AM; Cortés ME
    Hum Reprod; 2007 Nov; 22(11):2974-80. PubMed ID: 17895281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide, a somatostatin analog, reduces insulin secretion and increases renal Na+ excretion in lean essential hypertensive patients.
    Ferri C; De Mattia G; Bellini C; Laurenti O; Bravi C; Baldoncini R; Bonavita MS; Santucci A; Balsano F
    Am J Hypertens; 1993 Apr; 6(4):276-81. PubMed ID: 8507446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of insulin secretion and insulin sensitivity between normal and impaired glucose tolerance subjects with normal fasting plasma glucose.
    Tang KT; Ho LT; Jap TS; Chang TC; Ching KN; Lam HC; Wu MS; Lee SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Aug; 46(2):73-8. PubMed ID: 2177367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives.
    Sheu WH; Hsu CH; Chen YS; Jeng CY; Fuh MM
    Clin Endocrinol (Oxf); 1994 Feb; 40(2):249-55. PubMed ID: 8137525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorbitol as a marker for drug-induced decreases of variable duration in liver blood flow in healthy volunteers.
    Burggraaf J; Schoemaker RC; Lentjes EG; Cohen AF
    Eur J Pharm Sci; 2000 Dec; 12(2):133-9. PubMed ID: 11102741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.